期刊文献+

人PD-L1 cDNA的克隆及其胞外区蛋白在大肠杆菌中的表达 被引量:4

Cloning of the cDNA of human PD-L1 gene and the expression of its extracellular domain in Escherichia coli
原文传递
导出
摘要 目的 :克隆人PD L1基因的cDNA并构建PD L1胞外区基因的原核表达载体 ,在大肠杆菌中进行表达。方法 :以RT PCR法从活化的人淋巴细胞总RNA中 ,扩增并克隆PD L1的cDNA ,构建PD L1胞外区基因的原核表达载体 ,在大肠杆菌BL2 1(ED3)中进行表达并鉴定。结果 :克隆到PD L1cDNA编码区的全长序列 ,经DNA测序证明其与已报道的序列一致。同时构建了在羧基端带有His6标签的PD L1胞外区基因的原核表达载体 ,并在大肠杆菌中表达。免疫印迹分析表明 ,在IPTG诱导后表达的PD L1胞外区蛋白 ,相对分子质量 (Mr)为 2 50 0 0 ,与理论值的大小相符。该重组蛋白能与抗His6标签的单抗 (mAb)特异性反应。结论 :成功地克隆PD L1基因 ,其胞外区蛋白在大肠杆菌中获得表达 ,为利用PD L1转基因修饰移植物或以PD AIM: To clone human PD-L1 cDNA and construct a prokaryotic expression vector for the extracellular domain of PD-L1 gene. METHODS: The human PD-L1 cDNA was cloned by RT-PCR from the total RNA of activated human peripheral lymphocytes. The prokaryotic expression vector for the extracellular domain of PD-L1 gene was constructed and protein expression in E.coli strain BL21(DE3) was determined. RESULTS: The full-length coding sequence of PD-L1 gene was cloned and confirmed by DNA sequencing. The prokaryotic expression vector for the extracellular domain of PD-L1 gene fused with His_6 tag at the C-terminus was then constructed. The recombinant protein was expressed in (E.coli) after IPTG induction and identified by Western blot. The expressed product had a relative molecular mass (M_r) being 22 000, which was consistent with theoretical value. CONCLUSION: The PD-L1 gene was successfully cloned and the extracellular domain of the protein was expressed in E.coli, which lays the foundation for further study of the function of PD-L1.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2004年第6期659-663,共5页 Chinese Journal of Cellular and Molecular Immunology
基金 国家自然科学基金重点项目资助 (No .30 2 30 350 ) 国家重点基础研究发展规划 (973)项目资助 (No.G1 9990 5430 3和G2 0 0 0 570 0 6) 广东省"十五"科技计划重大专项基金资助 (A30 2 0 2 0 2 0 4 )
关键词 PD-L1 CDNA克隆 淋巴细胞 重组蛋白 PD-L1 cDNA cloning lymphocyte recombinant protein
  • 相关文献

参考文献12

  • 1Nishimura H, Honjo T. PD-1: an inhibitory immunoreceptor involved in peripheral tolerance[J]. Trends Immunol, 2001, 22(5): 265-268.
  • 2Nishimura H, Nose M, Hiai H, et al. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motifcarrying immunoreceptor[J]. Immunity, 1999, 11(2): 141-151.
  • 3Nishimura H, Okazaki T, Tanaka Y, et al. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice[J]. Science, 2001, 291(5502): 319-322.
  • 4Freeman GJ, Long AJ, Iwai Y, et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation[J]. J Exp Med, 2000, 192(7): 1027-1034.
  • 5Carreno BM, Collins M. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses[J]. Ann Rev Immunol, 2002, 20: 29-53.
  • 6Gao W, Demirci G, Strom TB, et al. Stimulating PD-1-negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival[J]. Transplantation, 2003, 76(6): 994-999.
  • 7Dong H, Zhu G, Tamada K, et al. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion[J]. Nat Med, 1999, 5(12): 1365-1369.
  • 8Iwai Y, Terawaki S, Ikegawa M, et al. PD-1 inhibits antiviral immunity at the effector phase in the liver[J]. J Exp Med, 2003, 198(1): 39-50.
  • 9Dubey C, Croft M, Swain SL. Naive and effector CD4 T cells differ in their requirements for T cell receptor versus costimulatory signals[J]. J Immunol, 1996, 157(8): 3280-3289.
  • 10Eppihimer MJ, Gunn J, Freeman GJ, et al. Expression and regulation of the PD-L1 immunoinhibitory molecule on microvascular endothelial cells[J]. Microcirculation, 2002, 9(2): 133-145.

二级参考文献39

  • 1Algre ML, Frauwirth KA, Thompson CB. T cell regulaiton by CD28and CTLA4 [J]. Nat Rev Immunol, 2001, 1(3): 220 -228.
  • 2Egen JG, Kuhns MS, Allison JP. CTLA4: new insights into its biological function and use in tumor immunotherapy [ J]. Nat Immunol,2002, 3(7): 611 -618.
  • 3Eagar TN, Karandikar NJ, Bluestone JA, et al. The role of CTLA4 ininduction and maintenance of peripheral T cell tolerance [ J]. Eur JImmunol, 2002, 32(4): 972 -981.
  • 4Grohmann U, Orabona C, Fallarino F, et al. CTLA4-Ig regulatestryptophan catabolism in vivo [ J ]. Nat Immunol, 2002, 3 ( 11 ):1097 - 1101.
  • 5Leung HT, Bradshaw J, Cleaveland JS, et al. Cytotoxic T lymphocyte-associated molecule-4, a high avidity receptor for CD80 andCD86, contains an intracellular localization motif in its cytoplasmictail [J]. JBiolChem, 1995, 270(42): 25107-25114.
  • 6Zhang Y, Allison JP. Interaction of CTLA4 with AP50, a clathrincoated pit adaptor protein [ J]. Proc Natl Acad Sci USA, 1997, 94(17): 9273 -9278.
  • 7Chuang E, Alegre ML, Duckett CS, et al. Interaction of CTLA4 withthe clathrin-associated protein AP50 results in liganddndependent endocytosis that limits cell surface expression [ J]. J Immunol, 1997,159(1): 144 - 151.
  • 8Eppihimer MJ,Gunn J,Freeman GJ,et al. Expression and regulation of the PD-L1 immunoinhibitory molecule on microvascular endothelial cells[J]. Microcirculation,2002,9(2):133-145.
  • 9Dong HD,Strome SE,Salomao DR,et al. Tumor-associated B7-H1 promotes T-cell apoptosis:A potential mechanism of immune evasion [J]. Nat Med,2002,8(8):793-800.
  • 10Mueller DL. T cells:A proliferation of costimulatory molecules [J]. Curr Biol,2000,10(6):227-230.

共引文献6

同被引文献18

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部